Last updated on August 2016

Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Atopic Dermatitis
  • Age: Between 19 - 70 Years
  • Gender: Male or Female
  • Other:
    Of either gender, aged ≥19 and ≤70 years
    Atopic dermatitis subjects who are coincident with Hanifin and Rajka diagnosis
    criteria
    Subacute and chronic atopic subjects who have atopic dermatitis symptoms continually
    at least 6 months
    Subjects with over moderate atopic dermatitis (SCORAD score > 20)
    Subjects who understand and voluntarily sign an informed consent form

You may not be eligible for this study if the following are true:

  • Subjects who have systemic infection
    Subjects who have human Immunodeficiency virus (HIV), hepatitis B virus (HBV), and
    hepatitis C virus (HCV)
    Subjects who need to take the medicine which is prohibited during this study
    Subjects who have asthma
    Subjects who can not stop treatment with topical steroids (group 1~5), oral
    antibiotics, whole body photochemotherapy, immunosuppressive drug within 4 weeks
    before the treatment visit
    Pregnant, breast-feeding women or women who plan to become pregnant during this study
    (Females of childbearing potential must have a negative urine pregnancy test)
    Subjects who currently participate in other clinical trial or participated in other
    clinical trial within 30 days
    Subjects who had a serious adverse events during stem cell therapy
    Subjects who had a hypersensitivity to antibiotics or antimycotics
    Subjects who creatinine value is more than two times of the upper limit of the normal
    range at screening test
    Subjects who aspartate transaminase/alkaline transaminase (AST/ALT) value is more
    than three times of the upper limit of the normal range at screening test
    Subjects who have any other condition which the investigator judges would make
    patients unsuitable for study participation

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.